HIV Mutation Detail Information

> L89M Search Result


Mutation Information
Mutation Site L89M
Mutation Type Amino acid level
Gene/Protein/Region Type PR
Relevant Drug tenofovir (TDF);lamivudine (LAM);lopinavir (LPV);ritonavir-boosted lopinavir
Country US;Thailand
Literature Information
PubMed PMID 30951600
Disease HIV infection/AIDS
Published Year 2020
Journal Journal of the Pediatric Infectious Diseases Society
Title Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study.
Author Viani RM,Ruel T,Alvero C,Fenton T,Acosta EP,Hazra R,Townley E,Palumbo P,Buchanan AM,Vavro C,Singh R,Graham B,Anthony P,George K,Wiznia A,P1093 Study Team .
Evidence Table 4

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation